pillbase.ru

Ogsiveo

Active substance: nirogacestat

nirogacestat hydrobromide

Centralised EU authorisationActive

Marketing holder: Merck Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • OGSIVEO
    TABLET, FILM COATED · NIROGACESTAT 100 mg/1
    82448-100
    SpringWorks Therapeutics, Inc.
  • OGSIVEO
    TABLET, FILM COATED · NIROGACESTAT 150 mg/1
    82448-150
    SpringWorks Therapeutics, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-36cc-730f-85f6-d8c622a7c45f,01a12091-15cb-7cb0-8fbe-45f2b536f0d0;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006071
Registration status
Active
ATC code
L01XX81
Sources
  • product · EMA · EMEA/H/C/006071 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006071 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006071 · Verified 2026-10-09